Synthesis, Crystal Structure, Structure−Activity Relationships, and Antiviral Activity of a Potent SARS Coronavirus 3CL Protease Inhibitor-Reference-Cited by-同舟云学术

Synthesis, Crystal Structure, Structure−Activity Relationships, and Antiviral Activity of a Potent SARS Coronavirus 3CL Protease Inhibitor

Published:2006-07-14 Issue:16 Volume:49 Page:4971-4980
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yang Syaulan¹,Chen Shu-Jen¹,Hsu Min-Feng¹,Wu Jen-Dar¹,Tseng Chien-Te K.¹,Liu Yu-Fan¹,Chen Hua-Chien¹,Kuo Chun-Wei¹,Wu Chi-Shen¹,Chang Li-Wen¹,Chen Wen-Chang¹,Liao Shao-Ying¹,Chang Teng-Yuan¹,Hung Hsin-Hui¹,Shr Hui-Lin¹,Liu Cheng-Yuan¹,Huang Yu-An¹,Chang Ling-Yin¹,Hsu Jen-Chi¹,Peters Clarence J.¹,Wang Andrew H.-J.¹,Hsu Ming-Chu¹

Affiliation:

1. TaiGen Biotechnology Co., Taipei 114, Taiwan, ROC, Institute of Biochemical Sciences, National Taiwan University, Taipei 106, Taiwan, ROC, Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan, ROC, Core Facility for Protein X-ray Crystallography, Academia Sinica, Taipei 115, Taiwan, ROC, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0603926

Reference23 articles.

1. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

2. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

3. Koch's postulates fulfilled for SARS virus

4. Pagetic skull

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. Ayurvedic and Chinese Herbs against Coronaviruses;Current Pharmaceutical Design;2024-06

3. Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity;Bioorganic & Medicinal Chemistry;2024-04

4. An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations;Science Translational Medicine;2024-03-13

5. Computer Aided Structure-Based Drug Design of Novel SARS-CoV-2 Main Protease Inhibitors: Molecular Docking and Molecular Dynamics Study;Computation;2024-01-20